Page 4,153«..1020..4,1524,1534,1544,155..4,1604,170..»

TiGenix completes the sale of its Dutch manufacturing facility to PharmaCell

Posted: Published on June 2nd, 2014

Regulated information 2 June, 2014 TiGenix completes the sale of its Dutch manufacturing facility to PharmaCell TiGenix to receive a total consideration of Euro 5.75 million PharmaCell will continue to manufacture ChondroCelect, which Sobi will market and distribute TiGenix to focus on bringing its development pipeline to patients Leuven, Belgium - 2 June, 2014 - TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, announced today that it has completed the sale of its Dutch production facility to PharmaCell BV for a total consideration of Euro 5.75 million. PharmaCell, a leading European contract manufacturing organisation active in the areas of cell therapy and regenerative medicine, has acquired the shares of TiGenix' wholly-owned subsidiary,TiGenix BV, which holds the Dutch manufacturing facility. The TiGenix state-of-the-art manufacturing facility is located in Sittard Geleen in the Netherlands. In 2012, the site passed a cGMP (current Good Manufacturing Practice) inspection by the Dutch authorities, and obtained approval from the European Medicines Agency for the production of ChondroCelect, the company's cell therapy product for cartilage repair in the knee. TiGenix has received an upfront payment of Euro 3.5 million, and will receive a final payment of Euro 0.75 million in 2017. ChondroCelect will continue … Continue reading

Posted in Cell Therapy | Comments Off on TiGenix completes the sale of its Dutch manufacturing facility to PharmaCell

Advances in Nuclear Cardiology & Cardiac CT, Tracy Callister, MD, FACC, Cedar Sinai 2014 – Video

Posted: Published on June 2nd, 2014

Advances in Nuclear Cardiology Cardiac CT, Tracy Callister, MD, FACC, Cedar Sinai 2014 29th annual case review with the experts 2014. By: nxtframemedia … Continue reading

Posted in Cardiology | Comments Off on Advances in Nuclear Cardiology & Cardiac CT, Tracy Callister, MD, FACC, Cedar Sinai 2014 – Video

CMS Grants Physician Specialty Designation for Interventional Cardiology – Video

Posted: Published on June 2nd, 2014

CMS Grants Physician Specialty Designation for Interventional Cardiology CMS has granted SCAI's request for a new specialty designation for interventional cardiology. Watch as SCAI Advocacy Committee Chair Peter L. Duffy, MD, MMM,... By: SCAITV … Continue reading

Posted in Cardiology | Comments Off on CMS Grants Physician Specialty Designation for Interventional Cardiology – Video

Plandai Biotechnology, Inc. Releases Shareholder Newsletter With Accompanying Video – Video

Posted: Published on June 2nd, 2014

Plandai Biotechnology, Inc. Releases Shareholder Newsletter With Accompanying Video SEATTLE, WA, United States, via eTeligis Inc., 05/20/2014 - - Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health,... By: Eteligis.com … Continue reading

Posted in Biotechnology | Comments Off on Plandai Biotechnology, Inc. Releases Shareholder Newsletter With Accompanying Video – Video

Independence Day Celebrations at Regional Centre for Biotechnology – Video

Posted: Published on June 2nd, 2014

Independence Day Celebrations at Regional Centre for Biotechnology All members at Regional Centre for Biotechnology soak up in patriotism and sing along- My India My Pride. By: unescorcbindia … Continue reading

Posted in Biotechnology | Comments Off on Independence Day Celebrations at Regional Centre for Biotechnology – Video

Common cholesterol drug greatly alters inflammatory response to common cold

Posted: Published on June 2nd, 2014

PUBLIC RELEASE DATE: 2-Jun-2014 Contact: Cody Mooneyhan cmooneyhan@faseb.org 301-634-7104 Federation of American Societies for Experimental Biology Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in the June 2014 issue of the Journal of Leukocyte Biology, researchers show that in individuals with asthma, statins significantly reduce the in vitro inflammatory response of human monocytes to rhinovirus (RV), the cause of the common cold. Not only does this discovery suggest that statins could help prevent or reduce the severity of asthma symptoms resulting from colds, but may also open the doors to further research into novel ways of controlling asthma attacks. "Our findings--that statins reduce rhinovirus-induced CXCL10 secretion from human monocytic cells--suggest that these frequently prescribed drugs may affect asthma exacerbations caused by the common cold in adults," said Lisa E. Wickert, Ph.D., a researcher involved in the work from the Department of Biomolecular Chemistry and Nutritional Sciences at the University of Wisconsin-Madison in Madison, Wisconsin. "We hope that these findings will provide motivation to study how statins not only affect asthma symptoms but more specifically viral-induced asthma exacerbations." To make their … Continue reading

Posted in Biology | Comments Off on Common cholesterol drug greatly alters inflammatory response to common cold

ASU Researcher Leads National Effort to Transform Undergraduate Biology Education

Posted: Published on June 2nd, 2014

Contact Information Available for logged-in reporters only Newswise During the past few decades, the field of biology has dramatically expanded, incorporating many diverse sub-disciplines and specialty areas such as microbiology and evolutionary biology. However, teaching biology to undergraduate students has not kept pace with the changes, and core biology curriculum varies widely from university to university, and classroom to classroom. In an effort to both capture the diversity of biology and condense what is taught, an Arizona State University researcher is leading a grassroots effort to improve biology education throughout the United States. Working with a team from the University of Washington to collect feedback from more than 240 biologists nationwide, ASU assistant professor Sara Brownell has developed a new, detailed core concept template called BioCore Guide. The guide is intended to provide an updated blueprint for educators to help them clarify the learning outcomes for undergraduate students majoring in general biology. What we really wanted to articulate was, at the end of four years, what do we want a graduating general biology major to know about the core concepts of biology? asked Brownell, an education researcher with ASUs School of Life Sciences in the College of Liberal Arts and … Continue reading

Posted in Biology | Comments Off on ASU Researcher Leads National Effort to Transform Undergraduate Biology Education

Global Synthetic Biology Market to Have an Impressive CAGR of 44.2% Till 2020 – Big Market Research

Posted: Published on June 2nd, 2014

Portland, Oregon (PRWEB UK) 2 June 2014 Big Market research publishes latest report "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Global Opportunity Analysis and Forecast - 2013 2020." The report forecasts that the global synthetic biology market would attain a value of $38.7 billion by 2020, registering a CAGR of 44.2% during 2014 - 2020. To get complete report visit at http://www.bigmarketresearch.com/synthetic-biology-market Synthetic biology is being commercialized; however, there are many technologies waiting for approval from respective governing bodies for commercialization. Yet, this market is expected to witness adoption in varied domains such as chemicals, pharmaceuticals, energy and agriculture. Important driving factors for the markets are assistance from private and government organizations, greater R&D and falling price of DNA synthesizing and sequencing. However, ethical issues, bio-security & bio-safety would work as impeding force for the growth of market. The report divides synthetic biology market on the basis of product, technology, application, and geography. Further, Synthetic biology product market is sub-divided into enabling products, enabled products and core products. As a result of greater research activities, enabling product would grow the fastest. Browse related report Global stem cell umbilical cord blood (ucb) market (storage service, therapeutics, application, geography) … Continue reading

Posted in Biology | Comments Off on Global Synthetic Biology Market to Have an Impressive CAGR of 44.2% Till 2020 – Big Market Research

Balti and Bioinformatics – Tom Connor – CLIMB – Video

Posted: Published on June 2nd, 2014

Balti and Bioinformatics - Tom Connor - CLIMB Tom Connor introduces the Cloud Infrastructure for Microbial Genomics (CLIMB) at Balti and Bioinformatics May 2014 - http://pathogenomics.bham.ac.uk/blog/2014/05/balti-and-bioinformatics-27th-may-2... By: pathogenomics … Continue reading

Posted in BioInformatics | Comments Off on Balti and Bioinformatics – Tom Connor – CLIMB – Video

Regence refusing to cover autism treatments

Posted: Published on June 2nd, 2014

Guest Opinion: The lone private holdout, Regence continues to exclude or limit coverage for key autism therapies. Next month, the state Supreme Court will decide whether to make them. Will the state Supreme Court force Regence to cover autism treatments? Credit: http://www.classactionsnews.com Regence BlueShield is now the lone remaining major health insurer in Washington State that refuses to reimburse parents for treatment prescribed to their autistic children. On June 12, Regence will defend its position before the Washington Supreme Court in O.S.T. v. Regence BlueShield. That's when the Supreme Court will consider whether to affirm a lower courts ruling that ordered Regence to cover speech, occupational and physical therapy treatments for autism. Today we all have friends who have been touched by autism. In the past 10 years, diagnoses of childhood autism have skyrocketed. Autism Spectrum Disorder (ASD) is now more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. In 2013, the U.S. Centers for Disease Control and Prevention estimated the prevalence of Autism Spectrum Disorder was one in 50 for children aged 6-17. That represents a 72 percent increase since 2007. Scientific research shows that early intervention and treatment of children with autism is highly effective. The … Continue reading

Comments Off on Regence refusing to cover autism treatments

Page 4,153«..1020..4,1524,1534,1544,155..4,1604,170..»